ACTRN12613001340729
Completed
Phase 4
Comparison of biocompatibility markers with two doses of citrate in regional citrate anticoagulation during hemodialysis
niversity Medical Center Ljubljana0 sites30 target enrollmentDecember 9, 2013
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Medical Center Ljubljana
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •adult patients, needing hemodialysis
Exclusion Criteria
- •acute illness, acute bleeding, known malignancy, current infection, immunosuppressive or anticoagulant therapy, known intolerance to citrate anticoagulation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
A comparison of biomarker and prosthetic complication in splinted and nonsplinted implant-supported prosthesesCTRI/2024/03/063788Dr. Divya Dharshini M
Not yet recruiting
Not Applicable
Comparison Of Levels of Three Types Of Biomarkers When RMGI And Biodentine Are Used As Barriers In Non Vital Tooth Bleaching.CTRI/2024/03/063737Dr Anwar S Pillai
Recruiting
Not Applicable
Comparative evaluation of clinical markers indicating hypoglycaemia treated with ImeglimiN and its eFfect on erythrocytes IN patIents with TYpe 2 diabetesType 2 diabetes mellitusD003924JPRN-jRCTs031220489Osonoi Takeshi30
Recruiting
Not Applicable
Bioequivalency study of two different Metformin formulationsIRCT20111107008022N7Reihaneh Pharmaceutical Company24
Not yet recruiting
Not Applicable
Bioequivalence study of two different Ciprofloxacin formulationsIRCT20111107008022N13Zagrous Darou Pharmaceutical Company24